Akebia Therapeutics, Inc. (NASDAQ:AKBA) Q2 2023 Earnings Call Transcript August 25, 2023 Akebia Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.06, expectations were $0.025. Operator: Good day and welcome to Akebia’s Second Quarter 2023 Financial Results Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be […]
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles